Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00175435
Status:
COMPLETED
Last Update Posted:
2010-11-02
First Post:
2005-09-11
Brief Title:
Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
Sponsor:
University of British Columbia
Organization:
University of British Columbia
Study Overview
Official Title:
Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
Status:
COMPLETED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will look at what happens to the level of protection against hepatitis B HB disease if a helper gel is applied to the skin over the injection site of a small dose of hepatitis B vaccine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None